HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,309-1,320 of 1,979
Drug study icon
CompletedEUCTR 2018-002749-12

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients with Major D...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Bipolarity, DepressionHistorical research record
Countries
Bulgaria
Sponsor
Intra-Cellular Therapies, Inc. (ITI)
Drug study icon
CompletedEUCTR 2019-004440-29

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients with Major Depressive Episodes...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Depression, BipolarityHistorical research record
Countries
Bulgaria
Sponsor
Intra-Cellular Therapies, Inc. (ITI)
Drug study icon
WithdrawnACTRN12619001569190

Safety study of risperidone Extended Release Capsules in schizophrenia

Official study title

Open-Label Single Dose Pilot Study to Assess Safety, Tolerability and Pharmacokinetics of Risperidone Extended Release Capsules in Patients with Schizophrenia, Schizoaffective Disorder or Bipolar 1 Disorder

This study was withdrawn before enrollment.

In Melbourne
Bipolarity, SchizophreniaInterventional studyAges 18–49
Countries
Australia
Sponsor
Lyndra Australia Pty Ltd
Drug study icon
CompletedNCT00217165

Taurine as an Anti-Manic Agent: A Study

Official study title

Taurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study.

This study has finished and is no longer accepting participants.

In Belmont
Bipolarity, DepressionMedication studyAges 18–68
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)
Drug study icon
CompletedEUCTR 2009-010276-16

A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolarity type I (Manic or Mixed Episodes) or Schizophrenia

Official study title

A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
Bipolarity, SchizophreniaHistorical research record
Countries
Germany
Sponsor
Eli Lilly
Drug study icon
TerminatedEUCTR 2021-006861-39

A Phase 2 Clinical Trial of GH001 in Patients with Bipolarity type II and a Current Major Depressive Episode (GH001-BD-202)

Official study title

A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive Episode (GH001-BD-202)

Original registry wording; source language not specified.

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
Bipolarity, DepressionHistorical research record
Countries
Germany, Netherlands
Sponsor
GH Research Ireland Limited

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.